Department of Embryology, Carnegie Institution, Baltimore, Maryland 21218, USA.
J Clin Invest. 2012 May;122(5):1726-33. doi: 10.1172/JCI61403. Epub 2012 Apr 9.
Retinoblastoma is a pediatric cancer that has served as a paradigm for tumor suppressor gene function. Retinoblastoma is initiated by RB gene mutations, but the subsequent cooperating mutational events leading to tumorigenesis are poorly characterized. We investigated what these additional genomic alterations might be using human retinoblastoma samples and mouse models. Array-based comparative genomic hybridization studies revealed deletions in the CDKN2A locus that include ARF and P16INK4A, both of which encode tumor suppressor proteins, in both human and mouse retinoblastoma. Through mouse genetic analyses, we found that Arf was the critical tumor suppressor gene in the deleted region. In mice, inactivation of one allele of Arf cooperated with Rb and p107 loss to rapidly accelerate retinoblastoma, with frequent loss of heterozygosity (LOH) at the Arf locus. Arf has been reported to exhibit p53-independent tumor suppressor roles in other systems; however, our results showed no additive effect of p53 and Arf coinactivation in promoting retinoblastoma. Moreover, p53 inactivation completely eliminated any selection for Arf LOH. Thus, our data reveal important insights into the p53 pathway in retinoblastoma and show that Arf is a key collaborator with Rb in retinoblastoma suppression.
视网膜母细胞瘤是一种儿科癌症,它是肿瘤抑制基因功能的典范。视网膜母细胞瘤是由 RB 基因突变引发的,但随后导致肿瘤发生的协同突变事件特征很差。我们使用人视网膜母细胞瘤样本和小鼠模型研究了这些额外的基因组改变可能是什么。基于阵列的比较基因组杂交研究显示,在人和小鼠的视网膜母细胞瘤中,CDKN2A 基因座发生缺失,包括 ARF 和 P16INK4A,它们都编码肿瘤抑制蛋白。通过小鼠遗传分析,我们发现 Arf 是缺失区域中关键的肿瘤抑制基因。在小鼠中,Arf 一个等位基因的失活与 Rb 和 p107 缺失协同作用,迅速加速视网膜母细胞瘤的发生,Arf 基因座经常发生杂合性丢失 (LOH)。已经有报道称,Arf 在其他系统中具有不依赖 p53 的肿瘤抑制作用;然而,我们的结果显示,p53 和 Arf 共同失活在促进视网膜母细胞瘤方面没有相加作用。此外,p53 失活完全消除了对 Arf LOH 的任何选择。因此,我们的数据揭示了视网膜母细胞瘤中 p53 途径的重要见解,并表明 Arf 是视网膜母细胞瘤抑制中与 Rb 合作的关键因素。